0001144204-12-059348.txt : 20121105 0001144204-12-059348.hdr.sgml : 20121105 20121105105510 ACCESSION NUMBER: 0001144204-12-059348 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121105 DATE AS OF CHANGE: 20121105 EFFECTIVENESS DATE: 20121105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-186486 FILM NUMBER: 121178913 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 D 1 primary_doc.xml X0706 D LIVE 0000894158 Synthetic Biologics, Inc. 617 DETROIT STREET, SUITE 100 ANN ARBOR MI MICHIGAN 48108 (734) 332-7800 NEVADA Adeona Pharmaceuticals, Inc. ADEONA PHARMACEUTICALS, INC. PIPEX PHARMACEUTICALS, INC. SHEFFIELD PHARMACEUTICALS INC Corporation true Jeffrey Riley c/o Synthetic Biologics 617 Detroit Street, Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Director C. Evan Ballantyne c/o Synthetic Biologics Ann Arbor MI MICHIGAN 48104 Executive Officer Jeffrey Kraws c/o Synthetic Biologics 617 Detroit Street, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Jeffrey Wolf c/o Synthetic Biologics 617 Detroit Street, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Steve Kanzer c/o Synthetic Biologics, Inc. 617 Detroit Street, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Scott Tarriff c/o Synthetic Biologics 617 Detroit Street, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Biotechnology Decline to Disclose 06 false 2012-10-30 false true false 0 Griffin Securities, Inc. 43229 None None 17 STATE STREET NEW YORK NY NEW YORK 10004 CA CALIFORNIA CT CONNECTICUT NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA TX TEXAS VT VERMONT VA VIRGINIA false 10800000 10800000 0 false 22 648000 0 In addition to cash fees, the Placement Agent received warrants to acquire an aggregate of 635,855 shares of common stock. 0 false Synthetic Biologics, Inc. /s/ Jeffrey Riley Jeffrey Riley President and Chief Executive Officer 2012-11-05